Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine versus Ritalin in pediatric outpatients with ADHD
IRCT20170606034348N1Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of atomoxetine and methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Babol University of Medical Sciences. Started Sep 2016; status: completed.
02
Drugs
atomoxetinemethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20170606034348N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170606034348N1.